Managing bevacizumab-induced intraocular inflammation

Managing bevacizumab-induced intraocular inflammation

The outcome of four cases of sterile endophthalmitis that developed after intravitreal injections of bevacizumab has been reported here. All four eyes received 1.25 mg/0.05 ml intravitreal bevacizumab from 0.2-ml aliquots for different etiologies. The inflammation predominantly involved the anterior...

Full description

Bibliographic Details
Main Authors: Subijay Sinha, Nagender Vashisht, Pradeep Venkatesh, Sat Pal Garg
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Apoptosis
glaucoma
intraocular pressure
retinal ganglion cells
retinal ischemia
tumor necrosis factor-alpha
Branch retinal vein occlusion
laser
Lucentis
macular edema
Microbial etiology
mucopurulent keratitis
suppurative keratitis
Intraoperative application of mitomycin C
mitomycin C
postoperative complications
preoperative subconjunctival injection
recurrence rate
recurrent pterygium
Cataract
inflammation
mydriasis
prevention and control
surgery
Cross-cylinder technique
photoastigmatic refractive keratectomy
refractive surgery
′BARC I-125 Ocu-Prosta seeds′
choroidal melanoma
plaque brachytherapy
retinoblastoma
vasoproliferative tumors
Asian Indian
Amaurosis
amaurosis hemianopia
capsulolenticular cataract
conjunctiva
lenticular cataract
leukoma
eye lid
ophthalmia chronica
ophthalmic purulentis
Interpretation
magnetic resonance imaging
orbit
ophthalmology
Antivascular endothelial growth factor
intravitreal bevacizumab
ocular inflammation
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=4;spage=311;epage=313;aulast=Sinha

Internet

http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=4;spage=311;epage=313;aulast=Sinha

Similar Items